The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
The Tumor Suppressor p53 Regulates Polarity of Self-Renewing Divisions in Mammary Stem Cells
Open accessAbstract
Stem-like cells may be integral to the development and maintenance of human cancers. Direct proof is still lacking, mainly because of our poor understanding of the biological differences between normal and cancer stem cells (SCs). Using the ErbB2 transgenic model of breast cancer, we found that self-renewing divisions of cancer SCs are more frequent than their normal counterparts, unlimited and symmetric, thus contributing to increasing numbers of SCs in tumoral tissues. SCs with targeted mutation of the tumor suppressor p53 possess the same self-renewal properties as cancer SCs, and their number increases progressively in the p53 null premalignant mammary gland. Pharmacological reactivation of p53 correlates with restoration of asymmetric divisions in cancer SCs and tumor growth reduction, without significant effects on additional cancer cells. These data demonstrate that p53 regulates polarity of cell division in mammary SCs and suggest that loss of p53 favors symmetric divisions of cancer SCs, contributing to tumor growth.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition, recent studies have also assigned stem-cell maintenance functions to p53 (Cicalese et al. 2009;Levine et al. 2016), demonstrating that all three family members have similar functions in quality control in reproduction, stem-cell maintenance, and tumor suppression, albeit with different specializations acquired during evolution.”
From Structural Evolution and Dynamics of the p53 Proteins (2017) · cites this paper as Cicalese et al. 2009
In the citing paper
“p53 is involved in restricting the self-renewal of several types of stem cells, including neural stem cells and hematopoietic stem cells (Cicalese et al., 2009; Liu et al., 2009; Meletis et al., 2006).”
From p53 at a glance (2010) · cites this paper as Cicalese et al., 2009
Citations
Cites
In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2
Vassilev, L. T., Vu, B. T., Graves, B., Carvajal, D., Podlaski, F., Filipovic, Z., Kong, N., Kammlott, U., Lukacs, C., Klein, C., et al. (2004) · Science · doi:10.1126/science.1092472 · Cited by 4,661
Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas
Xue, W., Zender, L., Miething, C., Dickins, R. A., Hernando, E., Krizhanovsky, V., Cordon-Cardo, C., & Lowe, S. W. (2007) · Nature · doi:10.1038/nature05529 · Cited by 2,473
In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells
Dontu, G., Abdallah, W. M., Foley, J. M., Jackson, K. W., Clarke, M. F., Kawamura, M. J., & Wicha, M. S. (2003) · Genes & Development · doi:10.1101/gad.1061803 · Cited by 2,406
Generation of a functional mammary gland from a single stem cell
Shackleton, M., Vaillant, F., Simpson, K. J., Stingl, J., Smyth, G. K., Asselin-Labat, M.-L., Wu, L., Lindeman, G. J., & Visvader, J. E. (2006) · Nature · doi:10.1038/nature04372 · Cited by 2,005
Restoration of p53 function leads to tumour regression in vivo
Ventura, A., Kirsch, D. G., McLaughlin, M. E., Tuveson, D. A., Grimm, J., Lintault, L., Newman, J., Reczek, E. E., Weissleder, R., & Jacks, T. (2007) · Nature · doi:10.1038/nature05541 · Cited by 1,820 · cited 2×
“Therapeutic Efficacy of p53 Restoration in Cancer SCs Three groups have recently reported that re-expression of p53 causes regression of different p53 null tumors, including lymphomas, sarcomas, and hepatocellular carcinomas (Martins et al., 2006; Ventura et al., 2007; Xue et al., 2007).”
BackgroundPurification and unique properties of mammary epithelial stem cells
Stingl, J., Eirew, P., Ricketson, I., Shackleton, M., Vaillant, F., Choi, D., Li, H. I., & Eaves, C. J. (2006) · Nature · doi:10.1038/nature04496 · Cited by 1,559
Dissecting temporal and spatial control of cytokinesis with a myosin II Inhibitor
Straight, A. F., Cheung, A., Limouze, J., Chen, I., Westwood, N. J., Sellers, J. R., & Mitchison, T. J. (2003) · Science · doi:10.1126/science.1081412 · Cited by 1,412
Asymmetric and symmetric stem-cell divisions in development and cancer
Morrison, S. J., & Kimble, J. (2006) · Nature · doi:10.1038/nature04956 · Cited by 1,410
Muller, W. J., Sinn, E., Pattengale, P. K., Wallace, R., & Leder, P. (1988) · Cell · doi:10.1016/0092-8674(88)90184-5 · Cited by 1,165
Stem Cells and Cancer: Two Faces of Eve
Clarke, M. F., & Fuller, M. (2006) · Cell · doi:10.1016/j.cell.2006.03.011 · Cited by 905
p53 induces differentiation of mouse embryonic stem cells by suppressing Nanog expression
Lin, T., Chao, C., Saito, S., Mazur, S. J., Murphy, M. E., Appella, E., & Xu, Y. (2005) · Nature Cell Biology · doi:10.1038/ncb1211 · Cited by 859
Modeling the Therapeutic Efficacy of p53 Restoration in Tumors
Martins, C. P., Brown-Swigart, L., & Evan, G. I. (2006) · Cell · doi:10.1016/j.cell.2006.12.007 · Cited by 600 · cited 2×
“Therapeutic Efficacy of p53 Restoration in Cancer SCs Three groups have recently reported that re-expression of p53 causes regression of different p53 null tumors, including lymphomas, sarcomas, and hepatocellular carcinomas (Martins et al., 2006; Ventura et al., 2007; Xue et al., 2007).”
BackgroundLiu, X., Holstege, H., van der Gulden, H., Treur-Mulder, M., Zevenhoven, J., Velds, A., Kerkhoven, R. M., van Vliet, M. H., Wessels, L. F. A., Peterse, J. L., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702969104 · Cited by 474
p53 suppresses the self-renewal of adult neural stem cells
Meletis, K., Wirta, V., Hede, S.-M., Nistér, M., Lundeberg, J., & Frisén, J. (2006) · Development · doi:10.1242/dev.02208 · Cited by 413
NUMB controls p53 tumour suppressor activity
Colaluca, I. N., Tosoni, D., Nuciforo, P., Senic-Matuglia, F., Galimberti, V., Viale, G., Pece, S., & Di Fiore, P. P. (2008) · Nature · doi:10.1038/nature06412 · Cited by 385
Sleeman, K. E., Kendrick, H., Ashworth, A., Isacke, C. M., & Smalley, M. J. (2005) · Breast Cancer Research · doi:10.1186/bcr1371 · Cited by 320
Daniel, C. W., De Ome, K. B., Young, J. T., Blair, P. B., & Faulkin, L. J. (1968) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.61.1.53 · Cited by 286
A mammary-specific model demonstrates the role of the p53 tumor suppressor gene in tumor development
Jerry, D. J., Kittrell, F. S., Kuperwasser, C., Laucirica, R., Dickinson, E. S., Bonilla, P. J., Butel, J. S., & Medina, D. (2000) · Oncogene · doi:10.1038/sj.onc.1203270 · Cited by 204
Spindle orientation, asymmetric division and tumour suppression in Drosophila stem cells
Gonzalez, C. (2007) · Nature Reviews Genetics · doi:10.1038/nrg2103 · Cited by 193
Development of Spontaneous Mammary Tumors in BALB/c p53 Heterozygous Mice
Kuperwasser, C., Hurlbut, G. D., Kittrell, F. S., Dickinson, E. S., Laucirica, R., Medina, D., Naber, S. P., & Jerry, D. J. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64853-5 · Cited by 190
Stem cells in the etiology and treatment of cancer
Zhang, M., & Rosen, J. M. (2005) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2005.12.008 · Cited by 137
Early life events and conditions and breast cancer risk: From epidemiology to etiology
Trichopoulos, D., Adami, H., Ekbom, A., Hsieh, C., & Λάγιου, Π. (2007) · International Journal of Cancer · doi:10.1002/ijc.23303 · Cited by 120
Delayed involution of the mammary epithelium in BALB/c-p53null mice
Jerry, D. J., Kuperwasser, C., Downing, S., Pinkas, J., He, C., Dickinson, E. S., Marconi, S. M., & Naber, S. P. (1998) · Oncogene · doi:10.1038/sj.onc.1202157 · Cited by 86
Cellular Senescence: Ex Vivo p53‐Dependent Asymmetric Cell Kinetics
Rambhatla, L., Bohn, S. A., Stadler, P. B., Boyd, J. T., Coss, R. A., & Sherley, J. L. (2001) · BioMed Research International · doi:10.1155/s1110724301000079 · Cited by 75
Bonnefoix, T., Bonnefoix, P., Verdiel, P., & Sotto, J. (1996) · Journal of Immunological Methods · doi:10.1016/0022-1759(96)00077-4 · Cited by 74
Li, Z., Ren, J., Li, H., Zhao Lu, K. O. N. G., & Zhu, H. (2004) · Cell Research · doi:10.1038/sj.cr.7290253 · Cited by 52
Altered mammary gland development in the p53+/m mouse, a model of accelerated aging
Gatza, C. E., Dumble, M. L., Kittrell, F. S., Edwards, D. G., Dearth, R. K., Lee, A. V., Xu, J., Medina, D., & Donehower, L. A. (2007) · Developmental Biology · doi:10.1016/j.ydbio.2007.10.004 · Cited by 32
Research works printed but not linked: 2
- Kise, 2001, Reductive coupling of aromatic oxims and azines to 1,2-diamines using Zn-MsOH or Zn-TiCl4, Tetrahedron Lett., 42, 2365, 10.1016/S0040-4039(01)00178-2 · doi:10.1016/s0040-4039(01)00178-2
- Lanzkron, 1999, Hematopoietic stem cell tracking in vivo: a comparison of short-term and long-term repopulating cells, Blood, 93, 1916, 10.1182/blood.V93.6.1916.406k15_1916_1921 · doi:10.1182/blood.v93.6.1916.406k15_1916_1921
Cited by
Greaves, M., & Maley, C. C. (2012) · Nature · doi:10.1038/nature10762 · Cited by 3,162
Cancer Stem Cells: Current Status and Evolving Complexities
Visvader, J. E., & Lindeman, G. J. (2012) · Cell Stem Cell · doi:10.1016/j.stem.2012.05.007 · Cited by 1,287
Oncogenic roles of EMT-inducing transcription factors
Puisieux, A., Brabletz, T., & Caramel, J. (2014) · Nature Cell Biology · doi:10.1038/ncb2976 · Cited by 1,040
Can we safely target the WNT pathway?
Kahn, M. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4233 · Cited by 1,034
Targeting p53 pathways: mechanisms, structures, and advances in therapy
Wang, H., Guo, M., Wei, H., & Chen, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01347-1 · Cited by 1,016
Metadata
- Authors
- Cicalese, A., Bonizzi, G., Pasi, C. E., Faretta, M., Ronzoni, S., Giulini, B., Brisken, C., Minucci, S., Di Fiore, P. P., & Pelicci, P. G.
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2009-09
- Volume
- 138
- Issue
- 6
- Pages
- 1083-1095
- ISSN
- 0092-8674 (ISSN-L)
- OpenAlex
- W2153051750
- Cited by
- 696
- References
- 27
- FWCI
- 32.07
- Type
- journal article
- Language
- en
- Open access
- bronze
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 1415 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.